Fabrizio Citarella

1.7k total citations
26 papers, 420 citations indexed

About

Fabrizio Citarella is a scholar working on Pulmonary and Respiratory Medicine, Oncology and Molecular Biology. According to data from OpenAlex, Fabrizio Citarella has authored 26 papers receiving a total of 420 indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Pulmonary and Respiratory Medicine, 16 papers in Oncology and 7 papers in Molecular Biology. Recurrent topics in Fabrizio Citarella's work include Lung Cancer Treatments and Mutations (12 papers), Cancer Immunotherapy and Biomarkers (5 papers) and Lung Cancer Research Studies (5 papers). Fabrizio Citarella is often cited by papers focused on Lung Cancer Treatments and Mutations (12 papers), Cancer Immunotherapy and Biomarkers (5 papers) and Lung Cancer Research Studies (5 papers). Fabrizio Citarella collaborates with scholars based in Italy, United States and United Kingdom. Fabrizio Citarella's co-authors include Giuseppe Tonini, Bruno Vincenzi, Aldo Pezzuto, Marco Russano, Daniele Santini, Francesco Pantano, Emanuela Dell’Aquila, Andrea Napolitano, Ivana T. Croghan and Michele Iuliani and has published in prestigious journals such as Journal of Clinical Oncology, Annals of Oncology and Oncotarget.

In The Last Decade

Fabrizio Citarella

19 papers receiving 417 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Fabrizio Citarella Italy 8 227 159 143 139 48 26 420
Marco Russano Italy 10 239 1.1× 166 1.0× 124 0.9× 139 1.0× 46 1.0× 37 422
Kwan Chee Allen Chan Hong Kong 7 203 0.9× 169 1.1× 177 1.2× 85 0.6× 73 1.5× 8 545
Kelvin Shenq Woei Siew Malaysia 5 206 0.9× 215 1.4× 156 1.1× 87 0.6× 41 0.9× 9 410
Song Dong China 11 250 1.1× 107 0.7× 115 0.8× 277 2.0× 41 0.9× 34 466
Burcu Çakar Türkiye 12 195 0.9× 108 0.7× 137 1.0× 85 0.6× 38 0.8× 49 434
Georgia Gomatou Greece 11 260 1.1× 75 0.5× 161 1.1× 270 1.9× 32 0.7× 33 522
Nicole Caixeiro Australia 10 154 0.7× 147 0.9× 96 0.7× 82 0.6× 26 0.5× 13 315
Oliver Stötzer Germany 9 214 0.9× 187 1.2× 155 1.1× 81 0.6× 26 0.5× 26 433
Theodore Stewart Gourdin United States 10 173 0.8× 83 0.5× 105 0.7× 133 1.0× 90 1.9× 39 374
İbrahim Petekkaya Türkiye 10 261 1.1× 121 0.8× 111 0.8× 83 0.6× 22 0.5× 24 382

Countries citing papers authored by Fabrizio Citarella

Since Specialization
Citations

This map shows the geographic impact of Fabrizio Citarella's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Fabrizio Citarella with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Fabrizio Citarella more than expected).

Fields of papers citing papers by Fabrizio Citarella

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Fabrizio Citarella. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Fabrizio Citarella. The network helps show where Fabrizio Citarella may publish in the future.

Co-authorship network of co-authors of Fabrizio Citarella

This figure shows the co-authorship network connecting the top 25 collaborators of Fabrizio Citarella. A scholar is included among the top collaborators of Fabrizio Citarella based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Fabrizio Citarella. Fabrizio Citarella is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Canale, Matteo, Eugenio Fonzi, Letizia Gnetti, et al.. (2025). Genomic and Transcriptomic Profiles in Smokers and Never-Smokers Lung Squamous Cell Carcinoma Patients. PubMed. Volume 16. 85–96. 1 indexed citations
2.
Wu, Xiujuan, Qiang Xu, Di Meng, et al.. (2025). The identification and prediction of lung adenocarcinoma prognosis using a novel gene signature associated with DNA replication. Translational Cancer Research. 14(3). 1971–1981.
3.
Federico, Alessandro Di, Kaiwen Wang, Monica F. Chen, et al.. (2025). First-line immunotherapy with or without chemotherapy versus BRAF plus MEK inhibitors for patients with BRAF V600E -mutated metastatic non-small cell lung cancer: The FRONT-BRAF study.. Journal of Clinical Oncology. 43(16_suppl). 8574–8574.
4.
Bria, Emilio, José Luís Costa, Claudio Sini, et al.. (2024). 1283P Advanced ALK-positive non-small cell lung cancer (NSCLC) patients: Real-world treatment patterns and outcomes from the Italian biomarker ATLAS database. Annals of Oncology. 35. S818–S818. 1 indexed citations
5.
Citarella, Fabrizio, Kazuki Takada, Priscilla Cascetta, et al.. (2024). Clinical implications of the family history in patients with lung cancer: a systematic review of the literature and a new cross-sectional/prospective study design (FAHIC: lung). Journal of Translational Medicine. 22(1). 714–714. 3 indexed citations
6.
Ricciuti, Biagio, Rohit Thummalapalli, Fabrizio Citarella, et al.. (2024). Clinical outcomes and post-progression retreatment in patients with metastatic NSCLC who complete two years of treatment with immune checkpoint blockade.. Journal of Clinical Oncology. 42(16_suppl). 8633–8633.
7.
8.
Russano, Marco, Alessio Cortellini, Fabrizio Citarella, et al.. (2023). Immunotherapy for Metastatic Non-Small Cell Lung Cancer: Therapeutic Advances and Biomarkers. Current Oncology. 30(2). 2366–2387. 12 indexed citations
9.
Russano, Marco, Giuseppe Perrone, Fabrizio Citarella, et al.. (2022). Uncommon EGFR mutations in non-small-cell lung cancer. 5. 30–30. 2 indexed citations
10.
Citarella, Fabrizio, Marco Russano, Giuseppe Perrone, et al.. (2022). Ineffective target therapy in non-small cell lung cancer harboring BRAF G466R mutation: a case report and biological rationale. 5. 19–19. 2 indexed citations
11.
Citarella, Fabrizio, et al.. (2021). Novel drugs, familiar interactions: ciprofloxacin may increase exposure to the RET inhibitor pralsetinib. Annals of Oncology. 32(6). 811–813.
12.
13.
Russano, Marco, Andrea Napolitano, Giulia Ribelli, et al.. (2020). Liquid biopsy and tumor heterogeneity in metastatic solid tumors: the potentiality of blood samples. Journal of Experimental & Clinical Cancer Research. 39(1). 95–95. 172 indexed citations
14.
Dell’Aquila, Emanuela, Grazia Armento, Michele Iuliani, et al.. (2020). Denosumab for cancer-related bone loss. Expert Opinion on Biological Therapy. 20(11). 1261–1274. 17 indexed citations
15.
Citarella, Fabrizio, Marco Russano, Francesco Pantano, et al.. (2020). Facing SARS-CoV-2 Outbreak in Immunotherapy Era. Future Oncology. 16(20). 1475–1485. 9 indexed citations
16.
Dell’Aquila, Emanuela, Claudia Angela Maria Fulgenzi, Alessandro Minelli, et al.. (2020). Prognostic and predictive factors in pancreatic cancer. Oncotarget. 11(10). 924–941. 61 indexed citations
17.
Citarella, Fabrizio, Marco Russano, Paolo Gallo, et al.. (2020). Steroid-Refractory Immune Related Hepatitis May Hide Viral Re-Activation. Future Science OA. 6(9). FSO614–FSO614. 1 indexed citations
18.
Santini, Daniele, Fabrizio Citarella, Bruno Vincenzi, et al.. (2019). Cabozantinib and apixaban: an hitherto unreported interaction. Experimental Hematology and Oncology. 8(1). 22–22. 7 indexed citations
19.
Rossi, Giovanni, Aldo Pezzuto, Claudio Sini, et al.. (2019). Concomitant medications during immune checkpoint blockage in cancer patients: Novel insights in this emerging clinical scenario. Critical Reviews in Oncology/Hematology. 142. 26–34. 47 indexed citations
20.
Pezzuto, Aldo, Fabrizio Citarella, Ivana T. Croghan, & Giuseppe Tonini. (2019). The Effects of Cigarette Smoking Extracts on Cell Cycle and Tumor Spread: Novel Evidence. Future Science OA. 5(5). FSO394–FSO394. 52 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Marco Russano Breakdown of academic impact, for papers by Kwan Chee Allen Chan Breakdown of academic impact, for papers by Kelvin Shenq Woei Siew Breakdown of academic impact, for papers by Song Dong Breakdown of academic impact, for papers by Burcu Çakar Breakdown of academic impact, for papers by Georgia Gomatou Breakdown of academic impact, for papers by Nicole Caixeiro Breakdown of academic impact, for papers by Oliver Stötzer Breakdown of academic impact, for papers by Theodore Stewart Gourdin Breakdown of academic impact, for papers by İbrahim Petekkaya
Rankless by CCL
2026